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Introduction
Sarcoidosis is an uncommon inflammatory disease char-
acterized by the presence of  noncaseating granulomas in 
affected organs (1). It is a multisystem disease with a highly 
variable clinical course, primarily manifesting with pulmo-
nary involvement. However, any organ may be involved, 
including the eyes, skin, liver, kidneys, central nervous sys-
tem, and spleen. Bone-marrow involvement is rare, and 
isolated extrapulmonary sarcoidosis occurs in fewer than 
5% of  cases (2). We report a case of  a patient who pre-
sented clinically as if  she had lymphoma (including positive 
PET findings), but subsequently was diagnosed with sarcoi-
dosis. She responded well to treatment with prednisone and 
hydroxychloroquine. 
Case report
A 52-year-old Caucasian female presented with a 4-
month history of  fevers, night sweats, weight loss, abdomi-
nal pain, and diarrhea. The patient reported an uninten-
tional 50-pound weight loss in the past 4 months. She de-
nied muscle weakness, skin rash, shortness of  breath, or 
vision problems. Her medical history was significant for 
diabetes and uterine fibroids. Social history revealed no 
recent travel and no history of  smoking or alcohol use. 
Family history was significant for colon cancer in her 
mother but no known autoimmune conditions. Review of  
systems was otherwise negative. Physical exam revealed an 
afebrile female with normal vital signs and a BMI of  43.4 
kg/m2, no palpable lymphadenopathy, and clear lung fields 
bilaterally. No petechiae, cyanosis, clubbing, neurologic 
focality, skin rash, or joint effusions were noted. 
Laboratory workup revealed white blood cell count of  
3.9 x 103 and a differential of  70.8% neutrophils, 16.7% 
lymphocytes, 7.5% monocytes, 4.3% eosinophils, and 0.7% 
basophils with normal hemoglobin, liver function tests, and 
calcium level. A workup for lymphoma was started. A CT 
of  the thorax revealed multiple enlarged mediastinal and 
hilar lymph nodes, the largest located at the subcarinal 
space and measuring 1.7 x 2.2 cm. This was followed up 
with a PET scan that showed high FDG uptake in lymph 
nodes in the neck (SUVmax 7.7), mediastinum (SUVmax 
44.7), and pulmonary hila (SUVmax 30.9 on right and 24.0 
on left), suggestive of  lymphoma (Figs. 1 and 2). 
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A subcarinal lymph-node biopsy showed noncaseating 
granulomas with no evidence of  necrosis. There were 
multinucleated giant cells within granulomas, and periph-
erally the granulomas were surrounded by lymphocytes. 
The biopsy was negative for fungal and mycobacterial or-
ganisms, with negative AFB and PAS stains. Thus, pathol-
ogy was not diagnostic of  lymphoma. However, there was 
still a clinical suspicion for lymphoma given the lack of  any 
significant pulmonary findings or extrapulmonary findings 
that would be consistent with sarcoidosis. Angiotensin-
converting enzyme concentrations were within the normal 
range. A CT-guided bone-marrow aspiration and biopsy 
was done again, showing noncaseating granulomas with 
cytogenics indicating no evidence of  B-cell or T-cell lym-
phoma. A peripheral smear revealed normal red- and 
white-cell maturation with adequate platelets.
With no pathology diagnostic of  lymphoma, we started 
treatment for possible atypical sarcoidosis. The patient was 
started on hydroxychloroquine 200 mg by mouth twice a 
day and a prednisone taper starting at 20 mg by mouth 
twice a day. One month after starting treatment for sarcoi-
dosis, the patient reported almost complete resolution of  
her symptoms, including resolution of  fevers, chills, night 
sweats, and weight loss and had tapered her prednisone to 
10 mg daily. A repeat PET scan showed a decrease in the 
activity levels of  hypermetabolic lymph nodes throughout 
the mediastinum and bilateral pulmonary hilar regions. 
The largest nodal mass within the subcarinal mediastinum 
regressed in size and activity from an SUV of  44.7 to 14.2. 
Hypermetabolic lymph nodes within the pulmonary hila 
regressed in activity; on the right, SUV decreased from 
30.9 to 12.1, and on the left, SUV decreased from 24.0 to 
10.4. These findings suggest a positive therapeutic response 
(Fig. 3). 
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Figure 1. 52-year-old female with sardoidosis. PET/CT co-
ronal fusion image with corresponding axial CT of chest 
showing multiple enlarged mediastinal and hilar lymph 
nodes.
Figure 2. 52-year-old female with sardoidosis. Axial FDG-
PET image of the chest showing high FDG uptake in the 
mediastinum (SUVmax of 44.7) and pulmonary hila 
(SUVmax of 30.9 on right and 24.0 on left).
Figure 3. 52-year-old female with sardoidosis. Axial FDG-
PET image of the chest done three months after starting 
treatment for sarcoidosis. This image shows interval de-
crease in activity of hypermetabolic lymph nodes through-
out the mediastinum and bilateral pulmonary hilar regions, 
suggesting a positive therapeutic response.
This is an atypical presentation for sarcoidosis. However, 
the pathology findings, a positive response to treatment, 
and improvement on PET scan make a convincing case 
that our patient has underlying sarcoidosis. 
Discussion
Sarcoidosis is a systemic, chronic, granulomatous disor-
der. Although the cause is unknown, the immune system 
clearly plays a central role in pathogenesis (3). The sarcoid 
granuloma contains a central follicle of  tightly packed epi-
theloid cells and multinucleated giant cells surrounded by 
lymphocytes, macrophages, monocytes, and fibroblasts. 
The initial inflammation is mainly composed of  activated 
CD4 T helper cells whose cytokines recruit other cells to 
help form the granulomas (4).
Respiratory symptoms are the most common presenting 
complaints and include dry cough, dyspnea, and nonspe-
cific chest pain—none of  which our patient had. Fever, 
weight loss, fatigue, and malaise are the presenting symp-
toms in 25% of  patients (5). At presentation, 95% of  pa-
tients have clinical evidence of  pumonary sarcoidosis, and 
more than 40% of  sarcoidosis patients have evidence of  
involvement of  the skin, peripheral lymph node, eye, or 
liver (6). 
Radiographic findings alone are inadequate to make a 
diagnosis of  sarcoidosis. Likewise, the presence of  noncase-
ating granulomas on biopsy is not definitive (7). It is essen-
tial to rule out other causes of  noncaseating granulomas 
first. Thus, every biopsy should be searched for other causes 
of  noncaseating granulomas including malignancy, myco-
bacteria, fungi, parasites, other infections, and foreign 
bodies (8).
PET, a molecular functional imaging technique, has be-
come the most important nuclear medicine imaging modal-
ity in the field of  lymphoma. It is able to detect occult dis-
ease missed by conventional imaging techniques (9). This 
case clearly illustrates that not every PET-positive lesion 
represents malignancy, and a tissue biopsy is mandatory to 
confirm the diagnosis. 
Inflammatory cells such as neutrophils, activated macro-
phages, and lymphocytes have increased 18F-FDG uptake, 
causing important tracer accumulation in inflammatory 
and infectious processes (10). Thus, false-positive findings 
with an SUV higher than 2.5 (which is suggestive of  malig-
nancy) have been reported in inflammatory and granulo-
matous diseases, such as aspergillosis, tuberculosis, We-
gener’s granulomatosis, and sarcoidosis (11). In one case 
series, five patients with mediastinal lymph node enlarge-
ment suggestive of  lymphoma, lung cancer, or sarcodoisis 
were studied with 18F-FDG PET/CT. This study illus-
trated that sarcoidosis can be a pitfall in PET/CT imaging, 
and may lead to false-positive results of  malignancy (12). 
Another study of  20 cases demonstrated the 18F-FDG 
PET sensitivity for sarcoid lesions in several areas: thoracic 
(100%), sinonasal (100%), and pharyngolaryngeal (80%). A 
high standardized uptake value on PET could be miscon-
strued as indicative of  malignancy, and clinical factors, pat-
terns of  FDG uptake, and newer PET radiotracers such as 
18-fluoro-methyltyrosine (18F-FMT) may aid in distin-
guishing this benign disease from malignant tumor (13).
A study group of  24 sarcoid patients with suspected ma-
lignancy underwent both 18F-FDG and 18F-FMT PET 
(14). All patients showed increased uptake of  18F-FDG and 
no increase in the accumulation of  18F-FMT in their lym-
phadenopathy. No neoplasm was confirmed in any patient. 
Since the uptake of  18F-FDG was positive in these sarcoid 
lesions, 18F-FDG PET could not differentiate sarcoidosis 
from malignant disease. This suggests that use of  18F-FMT 
PET in combination with 18F-FDG PET may be an effec-
tive method to distinguish sarcoidosis from malignancy.
Our case shows that PET scans can aid in the diagnosis 
of  sarcoidosis and might also be used to monitor therapeu-
tic response. Further research needs to be performed re-
garding the usefulness of  18F-FDG PET, as well as the use 
of  newer radiotracers such as 18F-FMT, for the diagnosis 
and followup of  sarcoid patients as well as for differentiat-
ing sarcoid from malignant lymphoma (10). 
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